ArticleBMC cancer2024

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

Peter Hoskin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.